Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts

Choline PET/CT for imaging prostate cancer: an update

(2013) Kazuhiro Kitajima et al.   ANNALS OF NUCLEAR MEDICINE

Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody

(2013) Catharina M. van Rij et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Molecular Imaging of Prostate Cancer with PET

(2013) H. Jadvar   JOURNAL OF NUCLEAR MEDICINE

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

(2013) S. M. Hillier et al.   JOURNAL OF NUCLEAR MEDICINE

The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research

(2013) Benjamin T. Ristau et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

(2012) A. Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer

(2012) Maarten Brom et al.   EJNMMI Research

Prospects in radionuclide imaging of prostate cancer

(2011) Susanne Lütje et al.   PROSTATE

Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a68Ga- and18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts

(2010) Rafke Schoffelen et al.   MOLECULAR CANCER THERAPEUTICS

Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases

(2009) Mohsen Beheshti et al.   SEMINARS IN NUCLEAR MEDICINE

New horizons in prostate cancer imaging

(2008) Gregory Ravizzini et al.   EUROPEAN JOURNAL OF RADIOLOGY